SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Traders are linking AVAXs sharp rally to institutional tokenization developments, particularly reports that NYSE/ICE is testing Avalanche for a 24/7 tokenized-securities platform, alongside broader RWA adoption and altcoin rotation. The reaction is broadly bullish, though some community members question the moves durability because of weak volume and repeated selloffs after prior pumps.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Regulatory clarity, particularly the pending U.S. CLARITY Act and related SEC/CFTC rulemaking, is the dominant catalyst around ZBCN, with traders speculating that clearer rules could support institutional adoption of payment and payroll projects. Bullish participants also point to Zebecs SuperApp, partnerships, staking, and buybacks, while skeptics argue that actual user growth, transaction volume, and token demand remain unproven and that legislative delays could weigh on sentiment.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

A reported U.S.-Denmark-Greenland security agreement has put CRMLs Tanbreez rare-earth project back in focus, with traders arguing that greater Western control could raise its strategic value and limit Chinese involvement. Bullish posts emphasize short-covering potential, while skeptics note the agreement is not a direct mining or funding commitment and does not change production timelines.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

The planned AerodromeVelodrome merger and expansion of the unified Aero protocol to Ethereum mainnet is the dominant catalyst, with traders viewing broader cross-chain liquidity and a potential challenge to Uniswap as major growth drivers. The community is largely bullish, though some remain cautious about rollout delays, competition, and persistent weak price action.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

A rebound in Bitcoin and MicroStrategy is driving bullish attention toward MSTY, with traders citing a daily golden cross, moves above key moving averages, and renewed upside in the MSTR-linked options strategy. The community is also focused on weekly distributions, while skeptics continue to warn that dividend income may not offset NAV erosion and volatility.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WeRides receipt of Spains first national permit for Level 4 autonomous passenger vehicles, alongside Uber and AVOMO, is drawing attention as a potential gateway to European commercial robotaxi operations. Traders remain divided, with some viewing the Madrid rollout and broader international expansion as validation, while others focus on continued losses, cash-intensive scaling and weak stock performance.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Growing real-world-asset tokenization interest, including reported progress on the CLARITY Act and Ondos DTCC-related integrations, is driving attention around ONDO. Traders are bullish on Ondos position in tokenized securities, while others caution that the token currently lacks direct protocol-revenue sharing and await a potential fee-switch proposal.

the cat on Base  community-run home for $BASECAT

Basecat

Basecat is drawing attention as a newly listed Coinbase meme token, with traders focusing on increased visibility, volume, liquidity and volatility. The community is divided between dip-buyers expecting a reversal and skeptics warning that the move resembles a pump-and-dump amid heavy selling and meme-coin oversaturation.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

The upcoming fiscal second-quarter earnings release is the main catalyst, with traders anticipating a strong report and possible guidance update. The bullish community is also focused on QNXs expanding role in physical AI, automotive and robotics through partners such as NVIDIA, while skeptics question growth, Alloy Kores lack of current revenue and management execution.

Gemini Space Station, Inc. is a holding company, which engages in building secure financial infrastructure for the next generation of money and markets, providing access for individuals and institutions to a financial future that is more open, fair, and secure. The firm offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

A strategic investment from Geminis Winklevoss-controlled fund at a substantial premium, alongside better-than-expected quarterly results, has fueled renewed interest in the crypto platform. Traders are debating whether the commitment can support a turnaround and force covering of the stocks elevated short interest, while skeptics view it as insider support for a struggling business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA acceptance of Intellias biologics license application for lonvo-z, with Priority Review for hereditary angioedema and a March 2027 PDUFA date, is driving attention. Traders are optimistic about potential commercialization and platform validation, while debate remains over financing needs, commercialization risk, and heavy short interest weighing on the stock.

Can Intellia's Pipeline Progress Create Long-Term Value Amid Rivalry?

NTLA wins FDA priority review for lonvo-z, with a March 10, 2027 decision, potentially adding its first product, while nex-z studies are progressing well.

FDA Accepts & Gives Priority Review to Intellia's BLA for HAE Drug

NTLA's BLA for lonvo-z wins FDA priority review for the treatment of HAE. A decision from the agency is expected by March 10, 2027.

3 Promising Genomics Stocks in the Spotlight in 2026 

Genomics is reshaping healthcare, with WGS, NEO and NTLA advancing diagnostics and precision medicine.

Cathie Wood’s Biotech Bet Intellia Secured An FDA Priority Review For Rare Genetic Disorder Therapy – Retail Sees Upside In NTLA’s Platform

Equity

The FDA accepted Intellia’s Biologics License Application for lonvoguran Ziclumeran for Hereditary Angioedema.

4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains

CRSP, NTLA, BEAM and EDIT offer distinct gene-editing opportunities, spanning commercial validation, late-stage catalysts and promising early-stage programs.

NTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues

Intellia's Q2 loss matches estimates, but revenues fall 46.2% as lower Regeneron collaboration revenues weigh on results.

Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates

Intellia Therapeutics (NTLA) delivered earnings and revenue surprises of 0.00% and -47.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Protagonist Therapeutics (PTGX) Beats Q2 Earnings Estimates

Protagonist Therapeutics (PTGX) delivered earnings and revenue surprises of +8.53% and -3.12%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

3 Promising Genomics Stocks to Add to Your Portfolio in 2026

Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid advances in personalized medicine and synthetic biology continue to transform the industry.

This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Wall Street analysts change ratings for Pentair, Intellia Therapeutics, Etsy, Nutrien, and Ionis Pharmaceuticals. See what other analysts say.read more...

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$12.14
Prev Close	$12.26
Open	$12.16
Dividend Yield	0.00%
50-Day Moving Average	$12.02
Beta	1.84
Avg. Volume	3.45M
PE Ratio	-3.62

52-Week High	$28.25
52-Week Low	$7.95
Market Capitalization	$1.7B
EPS (Annual)	-$3.81
Price to Book	2.34
Revenue Per Employee	$179,498.67

Feed

News

Sentiment

Earnings

Fundamentals

Info

NTLA Fundamentals